Appointment of Non-Executive Director
News Oct 17, 2014
The Board of Proteome Sciences plc has announced the appointment of Mr. Martin Diggle as a Non-Executive Director with immediate effect.
Mr. Diggle, 52, has worked in finance for over 30 years. He was a director and partner of UBS/Brunswick in Russia until 2003, following which he joined Vulpes Investment Management, where he is currently a director and partner.
He is an experienced specialist investor in life sciences and manages the Vulpes Life Sciences Fund, the registered holder of 33,400,217 ordinary shares in Proteome Sciences representing approximately15.6% of the Company’s ordinary share capital.
Mr. Diggle is currently a Non-Executive Director of Oxford Biomedica plc and Chronos Therapeutics Limited. Mr Diggle holds an M.A in Philosophy, Politics and Economics from Oxford University.
CRISPR Reveals the Sugary Secrets of the Cancer-related Notch ProteinNews
New research shows that the fucose and glucose modifications serve as quality-control markers that allow Notch to be transported to its final destination in the cell membrane.READ MORE
New Insights into Opioid Drug Activation Pave the Way for New TherapeuticsNews
Mount Sinai researchers have identified unique structural, biological and chemical insights in the way different opioid drugs activate receptors and specific signaling pathways.READ MORE